Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Q4 FY2021 Earnings Presentation
31 slides from Navin Fluorine International's earnings presentation, May 8, 2021
Slide 1: Cover letter to stock exchanges
May 08, 2021 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (East), Mumbai 400001, India. Mumbai 400051, India. Stock Code: 532504 Stock Code: NAVINFLUOR EQ Dear Sir / Madam, Sub.: Investor Presentation
Slide 2: Navin Fluorine International Limited Investor Presentation – Q4 & FY21
Navin Fluorine International Limited Investor Presentation – Q4 & FY21
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: YoY Highlights FY21 – Sustainable Growth
FY21 – Sustainable Growth High Value Businesses Operating Revenue +11% Rs. 1,133 crores 732 554 +32% Operating EBITDA YoY Highlights +19% FY20 FY21 Rs. 311 crores FY21 Margin at 27% FY21 Revenue Contribution 65% Operating PBT +19% Contribution from Rs. 269 crores High Value Businesses Margin at 24%
Slide 5: YoY Highlights Q4FY21 – Strong Performance continues
Q4FY21 – Strong Performance continues High Value Businesses Operating Revenue +22% Rs. 324 crores 207 158 +31% Operating EBITDA YoY Highlights +25% Q4FY20 Q4FY21 Rs. 84 crores Q4FY21 Margin at 26% Q4FY21 Revenue Contribution 64% Operating PBT +29% Contribution from Rs. 73 crores High Value Businesse
Slide 6: Sustainable Performance
Sustainable Performance (Rs. Crs) High Value Businesses Legacy Businesses Total Revenue +32% +11% -14% Strong growth momentum in High Value 732 468 1,133 401 1,022 Businesses 554 FY20 FY21 FY20 FY21 FY20 FY21 Operating EBITDA Operating PBT Margin 26% 27% Margin 22% 24% Legacy Businesses normalizing
Slide 7: Strong Performance continues
Strong Performance continues (Rs. Crs) High Value Businesses Legacy Businesses Total Revenue 207 117 324 193 107 296 Robust performance by High Value Businesses 103 158 265 Q4FY20 Q3FY21 Q4FY21 Q4FY20 Q3FY21 Q4FY21 Q4FY20 Q3FY21 Q4FY21 Operating EBITDA Operating PBT Margin 25% 27% 26% Margin 21% 24%
Slide 8: Business Vertical - Specialty Chemicals
Business Vertical - Specialty Chemicals Revenues (Rs. Crs) +26% +19% 131 453 104 381 Business continues to show strong growth driven by mix of new customers, new products and market share gain Leveraging our R&D capabilities and deep fluorination Q4FY20 Q4FY21 FY20 FY21 expertise to strengthen our n
Slide 9: Business Vertical - CRAMS
Business Vertical - CRAMS Revenues (Rs. Crs) +40% +62% 76 279 54 Strong performance driven by new customer acquisition and 173 repeat business from existing customers Q4FY20 Q4FY21 FY20 FY21 Good project flows from new as well as existing innovators 0% Cost improvement initiatives being undertaken f
Slide 10: Business Vertical - Inorganic Fluorides
Business Vertical - Inorganic Fluorides Revenues (Rs. Crs) +16% -7% 59 207 193 51 Performance improved quarter by quarter Q4FY20 Q4FY21 FY20 FY21 Widening of end user segments in few products 12% New international customer acquisitions to drive future growth FY21 88% India International 9
Slide 11: Business Vertical - Refrigerant Business
Business Vertical - Refrigerant Business Revenues (Rs. Crs) +4% -20% 56 58 261 208 Trade and service sectors showed demand uptick in Q4 International sales have shown good traction during the Q4FY20 Q4FY21 FY20 FY21 quarter Non-emissive application was steady during the year 46% 54% FY21 India Inter
Slide 12: Capacity Expansion - Multi-Purpose Plant (MPP)
Capacity Expansion - Multi-Purpose Plant (MPP) Capex to be funded Investing Rs. 195 crs will help commercialize new products in life science and crop science sectors in the through internal specialty chemicals business accruals & debt Through wholly Project will be executed through wholly owned subs
Slide 13: Capacity Expansion - High Performance Product (HPP)
Capacity Expansion - High Performance Product (HPP) Key Highlights Entered into a $410 million contract with a Global Company for manufacture and supply of a High-performance Product (HPP) in the fluorochemical space $410 Mn $61.5 Mn Project will be executed through wholly owned subsidiary Navin Flu
Slide 14: HPP Contract - Reinforcement of Trust
HPP Contract - Reinforcement of Trust Developed new capabilities by venturing into High Performance Product (HPP) Delivery on NFIL’s long term strategy with important steps in portfolio transformation Entered into seven-year contract of $410mn (i.e. approximately Rs. 2,800 crores) with a leading Glo
Slide 15: Business Strategy
N e PADMANABH MAFATLAL, GROUP BG Business Strategy How Navin Fluorine’s values have translated into business strengths....
Slide 16: Core Business Strategy
Core Business Strategy Increase share of our Presence into High- High Value Business demand specialized (CRAMS & Specialty) which product basket now contributes ~64% of the Topline Innovation & Change growth - Moving into the Customer’s clear new High-Performance choice - Strong pillar of Partnershi
Slide 17: Long Term Direction: Clear Focus on Core Business
Long Term Direction Clear Focus on Core Business Piramal Pharma and Navin Fluorine Mutually Agree on Piramal increasing its stake to 100% in Convergence Chemicals Navin Fluorine International Limited Piramal Group Focus area Focus area Continuing to grow its anesthetics Expanding High Value Business
Slide 18: Strategic Capital Re-allocation – Fully exit CCPL
Strategic Capital Re-allocation – Fully exit CCPL Rs. 65.1 Crores received for 49% Perpetual license to use the stake in CCPL + technical know-how for Rs. 7.9 Crores for leasehold rights development and marketing of select of the GIDC land earmarked for CCPL products Raw Material supply agreement wi
Slide 19: Financial Performance
N e PADMANABH MAFATLAL, GROUP Financial Performance
Slide 20: Standalone Profitability Statement
Standalone Profitability Statement Particulars (Rs. Crs.) Q4 FY21 Q4 FY20 Y-o-Y Change % Q3 FY21 Q-o-Q Change % FY21 FY20 Y-o-Y Change % Net Revenue from Operations 324.0 265.0 22% 296.6 9% 1,133.1 1,022.3 11% Raw Material 153.2 120.9 135.9 511.0 464.9 Employee Expenses 32.5 30.8 31.4 124.9 116.5 Ot
Slide 21: Standalone Balance Sheet
Standalone Balance Sheet ASSETS (Rs. Crs.) 31-Mar-21 31-Mar-20 EQUITY AND LIABILITIES (Rs. Crs.) 31-Mar-21 31-Mar-20 Non-current assets 861.3 846.0 EQUITY 1,650.1 1,388.9 Property, Plant and Equipment 347.8 359.1 Equity Share Capital 9.9 9.9 Capital work-in-progress 36.5 38.9 Right-of-use Assets 13.
Slide 22: Standalone Cashflow Statement
Standalone Cashflow Statement Particulars (Rs in Crs) 31-Mar-21 31-Mar-20 (A) Cash flow from operating activities Profit before tax 409.5 256.7 Adjustments for noncash items (64.7) 12.7 Operating profit before working capital changes 344.8 269.5 Working capital adjustments (67.7) (68.4) Cash flows g
Slide 23: Other Income Built-up
Other Income Built-up Q4 FY21 (Rs. Crs) Q4 FY20 (Rs. Crs) 19.7 5.3 -0.6 18.3 -0.8 4.4 -5.2 4.4 Reported One Off Gain MTM Gain Adjusted Reported One Off Gain MTM Gain Adjusted Other Income Other Income Other Income Other Income 22 * One-Off Gain is towards Sale of Investments On Standalone basis
Slide 24: Consolidated Profitability Statement
Consolidated Profitability Statement Particulars (Rs. Crs.) Q4 FY21 Q4 FY20 Y-o-Y Change % Q3 FY21 Q-o-Q Change % FY21 FY20 Y-o-Y Change % Net Revenue from Operations 336.4 276.6 22% 309.1 9% 1,179.4 1,061.6 11% Raw Material 160.7 125.7 142.5 537.4 483.8 Employee Expenses 36.9 35.1 36.2 141.7 130.8
Slide 25: Consolidated Balance Sheet
Consolidated Balance Sheet ASSETS (Rs. Crs.) 31-Mar-21 31-Mar-20 EQUITY AND LIABILITIES (Rs. Crs.) 31-Mar-21 31-Mar-20 Non-current assets 702.8 850.8 EQUITY 1,633.9 1,412.2 Property, Plant and Equipment 375.9 364.2 Equity Share Capital 9.9 9.9 Capital work-in-progress 94.9 38.9 Right-of-use Assets 2
Slide 26: Consistent Dividend Performance
Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Special Dividend 550% 550% ✓ Continuous Dividend over 12 years Final of 150% Interim + ✓ Special Dividend of 600% on FV of Special 150% Dividend Rs. 10 in FY12 of 75% 390% 300% + 350% ✓ Special Divided of 75% on FV of
Slide 27: NFIL at glance
9888 PADMANABH Ni MAFATLAL GROUP CH) NFIL at glance Responsible Care”
Slide 28: NFIL at glance
NFIL at glance Manufacturing plants strategically located closer to major ports Strong Clientele base in India & abroad, including Global Innovators Largest Integrated Specialty Fluorochemical Company in India Over 50 years of expertise in Handling Fluorine Built “India’s only plant with high pressu
Slide 29: Our Capabilities
Our Capabilities Manufacturing Raw Material Sourcing In-house R&D Fluorination Capabilities • Chemical Complex at Surat • Backward integration for Raw • State-of-the-art R&D centre – • Pioneered Manufacturing spread over 135 acres, houses material through 25% JV Navin Research Innovation of Refriger
Slide 30: Our Delivery
Our Delivery Commenced Specialty Commenced CRAMS Inorganic Fluorides & Refrigerants are Chemicals in 2000 business in 2011 traditional business since 1967 Specialty Chemicals – Inorganic Fluorides – FY21 – Revenue % CRAMS – 24% Refrigerants – 18% 40% 18% Specialty Chemicals – Inorganic Fluorides – R
Slide 31: Thank You Note
Thank You Note For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Ketan Sablok Mr. Jigar Kavaiya Chief Financial Officer +91 99206 02034 ket
Navin Fluorine International — Q4 FY2021 Earnings Presentation on 6ix